News

The delivery system can be used for pharmaceutical, biopharmaceutical, medical foods, and nutraceutical products. In addition to the existing New Zealand patent, this patent covers the company’s multi-phase,

The Collaborative Research Initiative will be a strategic expansion of the company’s ‘Project Boveri: Find the Cure,’ adding the ability to monitor hourly chromosome aneuploidy progression. ChromoCure’s technology

Salix Pharma said that FDA approval of Xifaxan 550mg tablets was based on a 299 subject, double-blind, placebo-controlled, multinational, Phase 3 clinical trial. Trial results demonstrated a positive

The gene expression assays are specifically designed for the workflow of Fluidigm’s integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers

Dara BioSciences said that the study will enroll approximately 75 volunteers and will be conducted at Quintiles’ Overland Park facility. The study’s main objectives are to determine the

Æterna Zentaris has posted a net income of $12.03m, or $0.19 per diluted share, compared to net loss of $14.49m, or $0.27 per diluted share, for the prior

The distribution agreement, announced in conjunction with positive data presented at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for

Alogliptin (once daily dosing) was discovered by Takeda’s wholly-owned subsidiary Takeda San Diego and is a member of the dipeptidyl peptidase IV (DPP-4) inhibitors class. DPP-4 selectively metabolizes

Cedax was originally discovered by Shionogi and Co and licensed to Schering-Plough. Cedax had received marketing approval from the FDA in 1995. Indicated for mild to moderate acute